|
|
Article: Flu epidemic threat spurs short-term growth of some Chinese pharma companies.
- Article from:
- China Business News
- Article date:
- June 2, 2009
CopyrightCOPYRIGHT 2009 Gale acknowledges Publisher's copyright in the text of the Publication and shall place users of that text on notice of that copyright interest. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Flu epidemic threat spurs short-term growth of some Chinese pharma companies
By Karl Zhong Shanghai. June 2. INTERFAX-CHINA - The looming threat of an influenza A (H1N1) epidemic has benefited some pharmaceutical companies in China, particularly domestic manufacturers of antiviral drugs, traditional Chinese medicine (TCM) and medical consumables, at least in the short term.
Since the end of April this year, the Chinese government has stepped up efforts to prevent the spread of the A/H1N1 flu virus in the country. On April 29, the Ministry of Health (MoH) issued an A/H1N1 flu diagnosis and treatment plan, which listed recommended antiviral drugs such as ...